Cargando…
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Psoriatic arthritis (PsA) is associated with a higher burden of co-morbidities such as obesity, cardiovascular disease, non-alcoholic fatty liver disease, inflammatory eye disease, inflammatory bowel disease, skin cancer and depression compared to the general population. In the last 20 years, the th...
Autores principales: | Patel, Sneha, Kumthekar, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814223/ https://www.ncbi.nlm.nih.gov/pubmed/34797530 http://dx.doi.org/10.1007/s40744-021-00397-7 |
Ejemplares similares
-
Obesity and Psoriatic Arthritis: A Narrative Review
por: Kumthekar, Anand, et al.
Publicado: (2020) -
Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
por: D’Angelo, Salvatore, et al.
Publicado: (2017) -
Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019) -
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021) -
Psoriatic arthritis: recent progress in pathophysiology and drug development
por: Veale, Douglas James
Publicado: (2013)